Other OTC - Delayed Quote USD

Targeted Medical Pharma, Inc. (TRGM)

0.0001 0.0000 (0.00%)
At close: July 27 at 10:47 AM EDT
Loading Chart for TRGM
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 11,681
  • Avg. Volume 0
  • Market Cap (intraday) 322,987
  • Beta (5Y Monthly) -0.35
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers' compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.

www.targetedmedicalpharma.com

30

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: TRGM

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TRGM
0.00%
S&P 500
6.30%

1-Year Return

TRGM
0.00%
S&P 500
22.67%

3-Year Return

TRGM
99.90%
S&P 500
22.63%

5-Year Return

TRGM
98.33%
S&P 500
74.37%

Compare To: TRGM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TRGM

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.05

  • Enterprise Value/EBITDA

    -3.33

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -57.86%

  • Return on Assets (ttm)

    -47.96%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.26M

  • Net Income Avi to Common (ttm)

    -3.04M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    82.64k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -174.02k

Company Insights: TRGM